Register for a webinar about hyaluronic acid products for knee injections

As we communicated previously, starting Jan. 1, 2020, Blue Cross Blue Shield of Michigan and Blue Care Network will consider some hyaluronic acid drugs to be preferred or covered and others to be nonpreferred or noncovered. You can find the full details in the article titled Blue Cross and BCN to cover select hyaluronic acid products, starting Jan. 1 in the November 2019 issue of The Record.

We're holding webinars to provide information about hyaluronic acid products for knee injections for Blue Cross' PPO, Medicare Plus Blue^SM PPO, BCN HMO^SM and BCN Advantage^SM members.

Click one of the following links to register for the webinar. All times are Eastern time.

• Thursday, Jan. 30, 1 to 1:30 p.m.
• Tuesday, Feb. 11, 1 to 1:30 p.m.
• Tuesday, Feb. 18, 10 to 10:30 a.m.

Once the host approves your registration, you'll receive a confirmation email with instructions for joining the session.

Note: We first communicated this change on Sept. 30, 2019, via a web-DENIS message and a news item on the ereferrals.bcbsm.com website.

Posted: November 2019
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network